• The latest GDP data show a sharp rebound in pharma exports in the second quarter of 2026 following a dip in prior quarters.
• The domestic economy remains on a moderate growth path, supported by solid consumer spending and elevated levels of business investment (linked to AI deployment).
• The labour market expanded at a slower pace in H1 2026. The unemployment rate has risen slightly to 5% in August.
